Hacker News new | ask | show | jobs
by f6v 1595 days ago
Not familiar with tumor immunology but I’d imagine it could be challenging to get CAR-Ts to infiltrate the tumor on demand.
1 comments
metiscus 1594 days ago
Not a medical guy but ipilimumab and friends may help do that. They blockade ctla-4 which downregulates cd4 activity. A combination may result in enhanced results.
link